Global Liquid Embolic Market is Expected to Grow USD 3.27 Billion by 2027

A new research report published by Fior Markets with the title Liquid Embolic Market by Product (Ethanol, Isobutyl-2-Cyanoacrylate, Bletilla Striata, Sodium Morrhuate), Material (ALGEL, Cyanoacrylate, N-Butyl-2 Cyanoacrylate, Absolute Alcohol, Polymer Dissolved In Non-Adhesive DMSO, Detergent, Others), Application (Tumour & Brain Cancer, Brain Arteriovenous Malformations, Brain Aneurysm, Ischemic Stroke), End Users (Ambulatory Surgical Centres, Hospitals), Regions, and Global Forecast 2020-2027.

The global liquid embolic market is expected to grow from USD 1.62 billion in 2019 to USD 3.27 billion by 2027, at a CAGR of 9.2% during the forecast period 2020-2027. The Asia-Pacific region stands as a promising market for liquid embolic. It is expected to grow at the highest CAGR during the forecast period owing to factors like technological advancements, increasing R&D activities and emerging players in the region. The markets in Japan, China, and India are proliferating, commanding significant shares in the regional market. However, the North America region holds the largest market share globally. This is thanks to modern equipment being available abundantly and the introduction of new groundbreaking surgical procedures. In this region, the United States of America is the biggest market for embolic liquid goods. Also, due to higher investment in health care research and the involvement of key players, the liquid embolic market in the Europe region is projected to experience substantial growth over the forecast period.

DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418253/request-sample

Key players in the global liquid embolic market are Medtronic plc, Cardinal Health, Emboflu, Johnson & Johnson, and Terumo Corporation, among others. Key companies are mainly focusing on developing new products, forming partnerships, and joint ventures to gain significant market share in the global liquid embolic market.

On the basis of product, the global liquid embolic market has been segmented into ethanol, isobutyl-2-cyanoacrylate, bletilla striata, and sodium morrhuate. On the basis of material, the global liquid embolic market has been segmented into ALGEL, cyanoacrylate, n-butyl-2 cyanoacrylate, absolute alcohol, polymer dissolved in non-adhesive DMSO, detergent, and others. On the basis of application, the global liquid embolic market has been segmented into tumour & brain cancer, brain arteriovenous malformations, brain aneurysm, and ischemic stroke. On the basis of end-user, the global liquid embolic market has been segmented into ambulatory surgical centres and hospitals. The main driver of the liquid embolic industry is the heightened occurrence of brain aneurysm worldwide.

ACCESS FULL REPORT: https://www.fiormarkets.com/report/liquid-embolic-market-by-product-ethanol-isobutyl-2-cyanoacrylate-bletilla-418253.html

About the report: 
The global liquid embolic market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on sales@fiormarkets.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.